Diagnostic Prediction of Pancreatic Masses

Chinese Academy of Medical Sciences & Peking Union Medical College

Status: Completed

Conditions: Pancreatic Masses

Study type: Observational

Funder types: Other

Identifiers

NCT06724055

2024-DPPM

Details and patient eligibility

About

The goal of this observational study is to learn if a strategy can be developed for differentiating autoimmune pancreatitis (AIP) and primary pancreatic lymphoma (PPL) from pancreatic ductal adenocarcinoma (PDAC) in patients presenting with pancreatic masses. The main question it aims to answer is:

What features, in the perspectives of clinical manifestation, laboratory tests, and imaging, can differentiate different kinds of pancreatic masses (AIP, PPL and PDAC)?

Participants will not be given any interventions since this is a retrospective observational study.

Enrollment: 110 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Inpatients presenting with pancreatic masses and eventually diagnosed with PPL, AIP, or PDAC (confirmed by pathologic results).

Trial design

110 participants in 3 patient groups

AIP

PPL

PDAC